×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
What Type Of Shareholders Make Up TFF Pharmaceuticals, Inc.'s (NASDAQ:TFFP) Share Registry?
Yahoo Lifestyle Canada
Every investor in TFF Pharmaceuticals, Inc. ( NASDAQ:TFFP ) should be aware of the most powerful shareholder groups...
4 days ago
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB ...
GlobeNewswire
The Leidos team's Next-Generation Medical Countermeasures (MCMs) Successfully Formulated with Company's Proprietary Thin Film Freezing...
2 weeks ago
TFF Pharmaceuticals, Cleveland Clinic to Advance Multiple Influenza Vaccines
Contract Pharma
TFF Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products...
2 weeks ago
TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
TFF Pharmaceuticals (TFFP) delivered earnings and revenue surprises of -9.09% and 35.33%, respectively, for the quarter ended March 2024.
3 weeks ago
TFF Pharmaceuticals and Cleveland Clinic to begin preclinical testing of universal influenza vaccine candidates
BioWorld MedTech
TFF Pharmaceuticals Inc. has announced it is advancing into preclinical testing multivalent universal influenza vaccine candidates to...
2 weeks ago
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Yahoo Finance
FORT WORTH, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage...
2 months ago
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
GlobeNewswire
FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”),...
1 month ago
Q2 2024 EPS Estimates for TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Increased by Roth Capital
Defense World
Read Q2 2024 EPS Estimates for TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Increased by Roth Capital at Defense World.
3 weeks ago
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of ...
Yahoo Finance
Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial 6 out of 6 Patients Who Completed the 12-Week Treatment...
3 weeks ago
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
GlobeNewswire
FORT WORTH, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”),...
1 month ago